Stroke in children: Inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 7, 2009, Pages 1130-1136

  Del Balzo, Francesca ^a   Spalice, Alberto ^a   Ruggieri, Martino ^b   Greco, Filippo ^b   Properzi, Enrico ^a   Iannetti, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Children, Risk factors, Stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; DNA; HEPARIN; HOMOCYSTEINE; INDOBUFEN; LUPUS ANTICOAGULANT; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ANTITHROMBIN DEFICIENCY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHICKENPOX; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HEAD INJURY; HEMIPARESIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; INBORN ERROR OF METABOLISM; INFANT; INFECTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MELAS SYNDROME; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PULMONARY VALVE STENOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; THROMBOEMBOLISM;

ADOLESCENT; AGE FACTORS; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; INTRACRANIAL HEMORRHAGES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 66749172226     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01290.x     Document Type: Article

References (21)

1. Barreirinho S, Ferro A, Santos M, Costa E, Pinto Basto J, Sousa A, et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 2003 28 : 134 8.
2. Riela A, Roach E. Etiology of stroke in children. J Child Neurol 1993 8 : 201 20.
3. Mancini J, Girard N, Chabrol B, Lamoureux S, Livet MO, Thuret I, et al. Ischemic cerebrovascular disease in children. Retrospective study of 35 patients. J Child Neurol 1997 12 : 193 9.
4. Dubreil Lastrucci DBM, Dawson DA, Munster M. Development of an internal restriction control in the PCR detection of the prothrombin 20210A mutation. Clin Lab Haem 1999 21 : 281 3.
5. Lawson S, Butler D, Enayat M, Williams M. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999 81 : 176 8.
6. Balasa V, Gruppo R, De Grauw A. Pediatric stroke and thrombophilia: a retrospective study. J Pediatr Hematol Oncol 1998 20 : 370.
7. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000 31 : 1283 8.
8. Lynch JK, Nelson KB, Curry CJ, Grether JK. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001 16 : 735 44.
9. Cardo E, Monros E, Colome C, Artuch R, Campistol J, Pineda M. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000 15 : 295 8.
10. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol 2001 43 : 220 5.
11. Alluri RV, Mohan V, Komandur S, Chawda K, Chaudhuri JR, Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 2005 12 : 40 4.
12. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylene tetrahydrofolate reductase gene, homocysteine and ischaemic cerebrovascular disease. Stroke 1997 28 : 1739 43.
13. Montiel-Manzano G, de la Peña-Díaz A, Majluf-Cruz A, Cesarman-Maus G, Corona-de la Peña N, Cruz-Cruz D, et al. National evaluation of the diagnosis of activated protein C resistance. Rev Invest Clin 2003 55 : 358 69.
14. Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 2000 486 : 159 62.
15. Jin L, Caldwell RB, Li-Masters T, Caldwell RW. Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol 2007 58 : 191 206. (Pubitemid 47026556)
16. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 667C→T polymorphism, and risk ischemic stroke. Results of a meta-analysis. Neurology 2002 59 : 529 36.
17. Nowak-Gottl U, Strater R, Heinecke A, Junker A, Koch HG, Schuierer G, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999 94 : 3678 82.
18. Lynch JK, Hirtz DG, De Veber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002 107 : 1400 4.
19. Braun K, Kappelle L, Kirkham F, De Veber G. Diagnostic pitfalls in paediatric ischaemic stroke. Dev Med Child Neurol 2006 48 : 985 90.
20. Steinlin M, Pfister I, Pavlovic J, Everts R, Boltshauser E, Capone Mori A, et al. The first three years of the Swiss Neuropediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms, and risk factors. Neuropediatrics 2005 36 : 90 7.
21. The Antiphospholipid Antibodies in Stroke Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990 21 : 1268 73.